^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Colon Cancer |
| Drug: | Avastin (bevacizumab) (VEGF-A inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Colon cancer...the panel recommends chemotherapy corresponding to initial therapy for metastatic disease (eg, FOLFIRI, FOLFOX, or CAPEOX chemotherapy alone or with bevacizumab; FOLFIRI or FOLFOX with panitumumab or cetuximab; FOLFIRINOX alone or with bevacizumab).
Colon Cancer...SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE - CHEMOTHERAPY REGIMENS...Trifluridine + tipiracil ± bevacizumab
Secondary therapy:
CAPOX; FOLFOX; FOLFIRI; trifluridine/tipiracil; FOLFIRINOX
